Guard Therapeutics International AB Stock
Equities
GUARD
SE0021181559
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38 SEK | +2.70% | +6.74% | +6.15% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 382M 36.53M |
---|---|---|---|---|---|
Net income 2024 * | -99M -9.46M | Net income 2025 * | -99M -9.46M | EV / Sales 2024 * | - |
Net cash position 2024 * | 70M 6.69M | Net cash position 2025 * | 46M 4.39M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.86
x | P/E ratio 2025 * |
-3.86
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.72% |
1 day | +2.70% | ||
1 week | +6.74% | ||
Current month | +12.43% | ||
3 months | +90.95% | ||
6 months | +22.98% | ||
Current year | +6.15% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 18-11-30 | |
Karin Botha
DFI | Director of Finance/CFO | 51 | 20-09-13 |
Michael Reusch
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
CHM | Chairman | 68 | 21-04-30 |
Göran Forsberg
BRD | Director/Board Member | 61 | 19-05-28 |
Fredrik Lehmann
BRD | Director/Board Member | 48 | 22-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 38 | +2.70% | 10,362 |
24-06-12 | 37 | +1.65% | 2,164 |
24-06-11 | 36.4 | +2.25% | 4,540 |
24-06-10 | 35.6 | -2.20% | 1,082 |
24-06-07 | 36.4 | +2.25% | 6,794 |
Delayed Quote Nasdaq Stockholm, June 13, 2024 at 12:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.15% | 36.14M | |
+46.03% | 56.61B | |
-7.53% | 39.62B | |
+36.02% | 39.25B | |
-9.38% | 28.28B | |
+12.31% | 26.44B | |
-16.38% | 20.12B | |
+30.79% | 12.51B | |
+28.57% | 12.48B | |
-0.36% | 12.2B |
- Stock Market
- Equities
- GUARD Stock